Below are current clinical trials.3 studies in Cryoablation for cancer
(open studies only).
Filter this list of studies by location, status and more.
This phase I/II trial studies the best dose and side effects of dendritic cell therapy, cryosurgery and pembrolizumab in treating patients with non-Hodgkin lymphoma. Vaccines, such as dendritic cell therapy made from a person's tumor cells and white blood cells may help the body build an effective immune response to kill tumor cells. Cryosurgery kills cancer cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving dendritic cell therapy, cryosurgery and pembrolizumab may work better at treating non-Hodgkin lymphoma.
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
This phase Ib/II trial studies how well dendritic cell therapy after cryosurgery in combination with pembrolizumab works in treating patients with stage III-IV melanoma that cannot be removed by surgery. Vaccines made from a person's white blood cells mixed with tumor proteins may help the body build an effective immune response to kill tumor cells. Cryosurgery, also known as cryoablation or cryotherapy, kills tumor cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Giving dendritic cell therapy after cryosurgery in combination with pembrolizumab may work better in treating patients with melanoma.
Oct. 26, 2017
- Cryotherapy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info.cfm?pg=cryo. Accessed June 20, 2017.
- Kurup AN, et al. Increasing role of image-guided ablation in the treatment of musculoskeletal tumors. The Cancer Journal. 2016;22:401.